Zolmitriptan Pregnancy and Breastfeeding Warnings
Zolmitriptan is also known as: Zomig, Zomig-ZMT
Zolmitriptan Pregnancy Warnings
The manufacturer lists miscarriage under adverse effects with a frequency of "rare".
Zolmitriptan has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality, and fetal abnormalities. Animal studies have also revealed maternal toxicity at high doses. There are no controlled data in human pregnancy. Zolmitriptan should only be given during pregnancy if the potential benefit justifies the potential risk to the fetus.
Zolmitriptan Breastfeeding Warnings
There are no data on the excretion of zolmitriptan into human milk. Because many drugs are excreted into human milk, caution is advised if zolmitriptan is to be administered to a nursing woman.
Animal studies have reported milk levels equivalent to maternal plasma levels at one hour after dose administration, and four times higher than plasma levels at four hours after dose administration (in the milk of lactating rats).
See Also...
- Zolmitriptan use while Breastfeeding (in more detail)
- zolmitriptan Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
